1-7 of 7
Zhong Zhang, MD
Close
Sort by
Journal Articles

MPL Mutation Profile in JAK2 Mutation-Negative Patients with Myeloproliferative Neoplasms.

Wanlong Ma, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Jennifer Uyeji, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 1891.
https://doi.org/10.1182/blood.V114.22.1891.1891
Published: 2009
Journal Articles

Splice Variant JAK2 Transcript Deleting Exon 14 in Patients with Chronic Myeloproliferative Neoplasms.

Wanlong Ma, Hagop Kantarjian, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 2161.
https://doi.org/10.1182/blood.V114.22.2161.2161
Published: 2009
Journal Articles

Three Novel Alternative Splicing Mutations in BCR-ABL1 detected in CML Patients with Resistance to Kinase Inhibitors.

Wanlong Ma, Hagop Kantarjian, Jorge Cortes, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 1107.
https://doi.org/10.1182/blood.V114.22.1107.1107
Published: 2009
Journal Articles

Significant Association Between Promoter Polymorphism of the Erythropoietin Gene and Myelodysplastic Syndrome.

Wanlong Ma, Hagop Kantarjian, MD, Ke Zhang, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Elihu Estey, MD, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 3825.
https://doi.org/10.1182/blood.V114.22.3825.3825
Published: 2009
Journal Articles

Mutation and Single-Nucleotide Polymorphism (rs16754) in Wilms Tumor-1 Gene Are Independent Prognostic Factors in Acute Myeloid Leukemia.

Wanlong Ma, Hagop Kantarjian, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 995.
https://doi.org/10.1182/blood.V114.22.995.995
Published: 2009
Journal Articles

Interleukin-1 Receptor Antagonist and Interleukin-1 beta: Different Roles in Patients with Chronic Lymphocytic Leukemia.

Zhong Zhang, MD, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Zeev Estrov, M.D., Alessandra Ferrajoli, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4948.
https://doi.org/10.1182/blood.V108.11.4948.4948
Published: 2006
Journal Articles

Epidermal Growth Factor Is an Independent Prognostic Factor in Patients with Chronic Lymphocytic Leukemia.

Zhong Zhang, MD, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Zeev Estrov, M.D., Alessandra Ferrajoli, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4952.
https://doi.org/10.1182/blood.V108.11.4952.4952
Published: 2006